Killing a killer: What next for smallpox?

PLoS Pathogens

Volumn 6, Issue 1, 2010, Pages

  McFadden, Grant ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; SMALLPOX VACCINE; ST 246; UNCLASSIFIED DRUG; VACCINIA VACCINE;

BIOLOGICAL WARFARE; CELLULAR IMMUNITY; CLADISTICS; COWPOX VIRUS; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; GENETIC VARIABILITY; HUMAN; HUMORAL IMMUNITY; MONKEYPOX VIRUS; NONHUMAN; NOTE; ORTHOPOXVIRUS; SMALLPOX; SMALLPOX VIRUS; VIRUS CELL INTERACTION; VIRUS DIAGNOSIS; VIRUS PATHOGENESIS; ZOONOSIS; ANIMAL; HISTORY; REVIEW;

VARIOLA VIRUS;

ANIMALS; HISTORY, 20TH CENTURY; HUMANS; SMALLPOX;

EID: 77649211332     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000727     Document Type: Note

References (29)

1. Henderson DA (2009) Smallpox: The Death of a Disease. New York: Prometheus Books. 334 p.
2. Tucker JB (2001) Scourge: The Once and Future Threat of Smallpox. New York: Atlantic Press Monthly. 291 p.
3. Alibek K, Handelman S (1999) Biohazard : the chilling true story of the largest covert biological weapons program in the world, told from the inside by the man who ran it. New York: Random House. xi, 319 p.
4. Shoham D, Wolfson Z (2004) The Russian biological weapons program: vanished or disappeared? Crit Rev Microbiol 30: 241-261.
5. Preston R (2002) The demon in the freezer: a true story. New York: Random House. 240 p.
6. Joklik WK, Moss B, Fields BN, Bishop DH, Sandakhchiev LS (1993) Why the smallpox virus stocks should not be destroyed. Science 262: 1225-1226.
7. Roizman B, Joklik W, Fields B, Moss B (1994) The destruction of smallpox virus stocks in national repositories: a grave mistake and a bad precedent. Infect Agents Dis 3: 215-217.
8. Smith GL, McFadden G (2002) Smallpox: anything to declare? Nat Rev Immunol 2: 521-527.
9. Institute of Medicine (2009) Live variola virus: considerations for continuing research. Washington (D.C.): National Academies Press, Available: http://www.iom.edu/Reports/2009/LiveVariola VirusContinuingResearch.aspx. Accessed 30 December 2009.
10. Esposito JJ, Sammons SA, Frace AM, Osborne JD, Olsen-Rasmussen M, et al. (2006) Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science 313: 807-812.
11. Li Y, Carroll DS, Gardner SN, Walsh MC, Vitalis EA, et al. (2007) On the origin of smallpox: correlating variola phylogenics with historical smallpox records. Proc Natl Acad Sci U S A 104: 15787-15792.
12. Jahrling PB, Hensley LE, Martinez MJ, Leduc JW, Rubins KH, et al. (2004) Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc Natl Acad Sci U S A 101: 15196-15200.
13. Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, et al. (2004) The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci U S A 101: 15190-15195.
14. Alejo A, Ruiz-Arguello MB, Ho Y, Smith VP, Saraiva M, et al. (2006) A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc Natl Acad Sci U S A 103: 5995-6000.
15. Dunlop LR, Oehlberg KA, Reid JJ, Avci D, Rosengard AM (2003) Variola virus immune evasion proteins. Microbes Infect 5: 1049-1056.
16. McFadden G (2004) Smallpox: an ancient disease enters the modern era of virogenomics. Proc Natl Acad Sci U S A 101: 14994-14995.
17. Mohamed MR, Rahman MM, Lanchbury JS, Shattuck D, Neff C, et al. (2009) Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc Natl Acad Sci U S A 106: 9045-9050.
18. Artenstein AW (2008) New generation small-pox vaccines: a review of preclinical and clinical data. Rev Med Virol 18: 217-231.
19. Damon IK, Davidson WB, Hughes CM, Olson VA, Smith SK, et al. (2009) Evaluation of smallpox vaccines using variola neutralization. J Gen Virol 90: 1962-1966.
20. Cello J, Paul AV, Wimmer E (2002) Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297: 1016-1018.
21. Domi A, Moss B (2005) Engineering of a vaccinia virus bacterial artificial chromosome in Escherichia coli by bacteriophage lambda-based recombination. Nat Methods 2: 95-97.
22. Yao XD, Evans DH (2003) High-frequency genetic recombination and reactivation of orthopoxviruses from DNA fragments transfected into leporipoxvirus-infected cells. J Virol 77: 7281-7290.
23. Domi A, Moss B (2002) Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proc Natl Acad Sci U S A 99: 12415-12420.
24. Bugl H, Danner JP, Molinari RJ, Mulligan JT, Park HO, et al. (2007) DNA synthesis and biological security. Nat Biotechnol 25: 627-629.
25. Wimmer E, Mueller S, Tumpey T, Taubenberger J (2009) Synthetic viruses: a new opportunity to understand and prevent viral disease. Nature Biotechnology 27: 1163-1172.
26. WHO recommendations concerning the distribution, handling and synthesis of variola virus DNA, May 2008. Wkly Epidemiol Rec 83: 393-395.
27. Parker S, Nuara A, Buller RM, Schultz DA (2007) Human monkeypox: an emerging zoonotic disease. Future Microbiol 2: 17-34.
28. Weaver JR, Isaacs SN (2008) Monkeypox virus and insights into its immunomodulatory proteins. Immunol Rev 225: 96-113.
29. Moore ZS, Seward JF, Lane JM (2006) Smallpox. Lancet 367: 425-435.